Status:

COMPLETED

Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Lead Sponsor:

Massachusetts General Hospital

Collaborating Sponsors:

Patient-Centered Outcomes Research Institute

Palliative Care Research Cooperative Group

Conditions:

Lung Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer and their families.

Detailed Description

Patients with serious cancers, like advanced lung cancer, often experience physical symptoms, such as pain or shortness of breath. In addition, both patients and their loved ones (family and friends) ...

Eligibility Criteria

Inclusion

  • Patient Eligibility Criteria
  • Diagnosed with advanced non-small cell lung cancer being treated with non-curative intent, and informed of advanced disease within the prior twelve weeks
  • Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 3 (symptomatic and in bed \>50% of the day)
  • The ability to read and respond to questions in English or Spanish
  • Receiving primary cancer care at one of the participating sites
  • Age \> or = 18 years
  • Lives in a state where their institutions' palliative care clinicians are licensed to practice
  • Caregiver Eligibility Criteria
  • Relative or friend who is identified by the patient participant and lives with the patient or has contact with them at least twice per week
  • The ability to read and respond to questions in English or Spanish
  • Age \> or = 18 years

Exclusion

  • Patient Exclusion Criteria
  • Already receiving outpatient palliative care or hospice services
  • Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation
  • Caregiver Exclusion Criteria
  • Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation

Key Trial Info

Start Date :

June 15 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2024

Estimated Enrollment :

1798 Patients enrolled

Trial Details

Trial ID

NCT03375489

Start Date

June 15 2018

End Date

December 31 2024

Last Update

May 16 2025

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

2

City of Hope

Los Angeles, California, United States, 91010

3

University of California - San Francisco

San Francisco, California, United States, 94121

4

University of Colorado

Aurora, Colorado, United States, 80045